VECCHIO, GIANCARLO
 Distribuzione geografica
Continente #
EU - Europa 18.279
AS - Asia 4.974
NA - Nord America 4.815
SA - Sud America 819
AF - Africa 131
Continente sconosciuto - Info sul continente non disponibili 8
OC - Oceania 5
Totale 29.031
Nazione #
IT - Italia 13.446
US - Stati Uniti d'America 4.638
SG - Singapore 2.918
RU - Federazione Russa 1.924
CN - Cina 939
NL - Olanda 847
BR - Brasile 695
HK - Hong Kong 519
DE - Germania 367
SE - Svezia 335
FI - Finlandia 290
VN - Vietnam 230
UA - Ucraina 219
FR - Francia 197
IE - Irlanda 173
GB - Regno Unito 167
CA - Canada 117
IN - India 79
PL - Polonia 61
ZA - Sudafrica 52
ES - Italia 48
BD - Bangladesh 47
AR - Argentina 42
TR - Turchia 37
MX - Messico 36
IQ - Iraq 32
AL - Albania 31
CH - Svizzera 30
EC - Ecuador 28
CI - Costa d'Avorio 20
ID - Indonesia 18
BG - Bulgaria 16
IL - Israele 16
IR - Iran 16
JP - Giappone 15
RO - Romania 15
AT - Austria 14
BE - Belgio 14
PK - Pakistan 14
AE - Emirati Arabi Uniti 13
UZ - Uzbekistan 13
VE - Venezuela 12
GR - Grecia 11
LT - Lituania 11
UY - Uruguay 10
CL - Cile 9
DK - Danimarca 9
PY - Paraguay 9
SA - Arabia Saudita 9
CZ - Repubblica Ceca 8
DZ - Algeria 8
TN - Tunisia 8
AZ - Azerbaigian 7
CO - Colombia 7
KE - Kenya 7
PT - Portogallo 7
KR - Corea 6
EU - Europa 5
HU - Ungheria 5
KZ - Kazakistan 5
OM - Oman 5
PE - Perù 5
RS - Serbia 5
SI - Slovenia 5
TH - Thailandia 5
MA - Marocco 4
MY - Malesia 4
NP - Nepal 4
SM - San Marino 4
TW - Taiwan 4
AU - Australia 3
BY - Bielorussia 3
DO - Repubblica Dominicana 3
EG - Egitto 3
JO - Giordania 3
KG - Kirghizistan 3
LU - Lussemburgo 3
MD - Moldavia 3
NG - Nigeria 3
PA - Panama 3
AM - Armenia 2
BA - Bosnia-Erzegovina 2
BB - Barbados 2
BW - Botswana 2
CR - Costa Rica 2
CW - ???statistics.table.value.countryCode.CW??? 2
DM - Dominica 2
ET - Etiopia 2
GN - Guinea 2
GT - Guatemala 2
HN - Honduras 2
HR - Croazia 2
JM - Giamaica 2
LK - Sri Lanka 2
LY - Libia 2
ML - Mali 2
NI - Nicaragua 2
PS - Palestinian Territory 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
Totale 28.996
Città #
Singapore 1.175
Rome 982
Naples 740
Milan 723
Moscow 537
Hong Kong 519
Chandler 464
Jacksonville 363
Ashburn 312
Florence 248
Millbury 244
Beijing 231
Turin 228
Princeton 224
Bologna 213
Palermo 203
Santa Clara 181
Nanjing 176
Bari 149
Wilmington 137
Catania 127
Los Angeles 126
Padova 119
Buffalo 114
Boston 113
Amsterdam 104
Ho Chi Minh City 90
Napoli 89
Nanchang 84
Pescara 73
Brescia 70
Kronberg 67
Perugia 67
The Dalles 67
Verona 66
Houston 65
Parma 64
Genoa 60
Ottawa 58
Munich 57
Salerno 57
São Paulo 56
Trieste 56
Cagliari 53
Messina 52
Dallas 50
Pisa 50
New York 47
Boardman 44
Redondo Beach 44
Reggio Emilia 43
Frankfurt am Main 42
Hanoi 42
Falls Church 41
Pavia 40
Venice 40
Kunming 39
Modena 38
Shenyang 37
Monza 35
Norwalk 34
Ann Arbor 33
Treviso 32
Turku 32
Caserta 31
Tianjin 29
Lucca 28
Seattle 28
Ancona 27
Ferrara 26
Bergamo 25
Reggio Calabria 25
Hebei 24
Jiaxing 24
Stockholm 24
Vicenza 24
Hefei 23
Johannesburg 23
Warsaw 23
Afragola 22
Changsha 22
Toronto 22
Avellino 21
Montreal 21
Brooklyn 20
Chicago 20
Siena 20
Campobasso 19
Helsinki 19
London 19
Orem 19
Taranto 19
Tirana 19
Cascina 18
Rio de Janeiro 18
Augusta 17
Brasília 17
Cinisello Balsamo 17
Hangzhou 17
Mexico City 17
Totale 11.553
Nome #
La cascata delle MAPK come bersaglio terapeutico per i carcinomi della tiroide. 14.595
[On the transport of thyroxine by the serum proteins of the Ammocoete of Petromyzon planeri Bl.] 128
The kinase inhibitor PP1 blocks tumorigenesis induced by RET oncogenes 127
Genetic Alterations in differentiated thyroid cancer:what can be expected for gene expression profiling of thyroid carcinomas 125
Human a-L-fucosidase-1 attenuates the invasive properties of thyroid cancer 125
The Insulin Receptor Substrate (IRS)-1 recruits Phosphatidylinositol 3-Kinase to Ret: evidence for a competition between Shc and IRS-1 for the binding to Ret. 119
Patologia Generale 115
AXL Is a Novel Predictive Factor and Therapeutic Target for Radioactive Iodine Refractory Thyroid Cancer 112
ONYX-015, an E1B gene-defective adenovirus,induces cell death in human anaplastic thyroid carcinoma cell lines. 111
Aspetti diagnostici di mutanti della regione HBsAg in pazienti immunocompromessi con riattivazione dell’infezione da virus dell’epatite B 111
Generation and characterization of novel monoclonal antibodies to the Ret receptor tyrosine kinase 110
Transformation of differentiated rat thyroid epithelial cells by viral and cellular oncogenes 110
Human papilloma virus 16E7 oncogene does not cooperate with ret/ptc 3 oncogene in the neoplastic transformation of thyroid cells in transgenic mice 109
Nino Salvatore tenth anniversary memorial meeting:thyroid and beyond 107
Constitutive expression of transforming growth factor alpha does not transform rat thyroid epithelial cells. 105
Espressione dei genomi virali in cellule infettate da MSV e da MuLV 105
Different mutations of the RET gene cause different human tumoral diseases. 104
Molecular mechanisms of RET activation in human cancer 103
Polyribosomes from rat thyroid gland 103
Involvement of H4(D10S170) protein in ATM-dependent response to DNA damage. 102
ZD6474, an orally available inhibitor of KDR tyrosine kinase activity, efficiently blocks oncogenic RET kinases 102
Cloning and characterization of H4 (D10S170), a gene involved in RET rearrangements in vivo. 102
H4(D10S170),a gene frequently rearranged with RET in papillary thyroid carcinomas:functional characterization. 101
Ret-mediated mitogenesis requires Src kinase activity. 101
RET ONCOGENE ACTIVATION IN HUMAN THYROID NEOPLASMS IS RESTRICTED TO THE PAPILLARY CANCER SUBTYPE 100
TPA induces a block of differentiation and increases the susceptibility to neoplastic transformation of a rat thyroid epithelial cell line 100
A dimeric mutant of human pancreas ribonuclease with selective antitumor action 100
Antitumor pancreatic-type RNases 100
Antineoplastic ribonucleases selectively kill thyroid carcinoma cells via caspase-mediated induction of apoptosis 99
Fissazione degli ormoni tiroidei al micrococcus lysodeikticus 99
Studies of some immunological properties of thyroid iodoproteins 99
Signaling through ras is essential for ret oncogene induced cell differentiation in PC12 cells 98
[On the extracellular localization of the iodide compartment: distribution of I-131 labelled NaI and of Na22 labelled NaCl in the mouse bearing an ascites tumor (Ehrlich's adenocarcinoma).] 98
Onyx-015 enhances radiation-induced death of human anaplastic thyroid carcinoma cells 97
The TRK and RET tyrosine kinase oncogenes cooperate with ras in the neoplastic transformation of a rat thyroid epithelial cell line. 97
High prevalence of RET/PTC rearrangements in Ukrainian and Belarussian post-Chernobyl thyroid papillary carcinomas: a strong correlation between RET/PTC3 and the solid-follicular variant. 96
Highly selective toxic and proapoptotic effects of two dimeric ribonucleases on thyroid cancer cells compared to the effects of doxorubicin 96
High frequency of activation of tyrosine kinase oncogenes in human papillary thyroid carcinoma 96
Aspetti strutturali e fuzionali delle iodoproteine tiroidee 96
I geni oncosoppressori in "Patologia Generale" IV Ed, Pontieri-Russo-Frati 94
Glial cell line-derived neurotrophic factor differentially stimulates ret mutants associated with the multiple endocrine neoplasia type 2 syndromes and Hirschsprung's disease 93
Effetti di una sostanza ad azione anti-tiroidea,l'1- metil-2 -mercapto-imidazolo(tapazolo) sulla iodazione e la biosintesi delle iodoproteine tiroidee di ratto 93
Recent advances in understanding immune phenotypes of thyroid carcinomas: Prognostication and emerging therapies [version 1; referees: 2 approved] 92
DIRECT-DETECTION OF PROVIRAL GAG SEGMENT OF HUMAN-IMMUNODEFICIENCY-VIRUS IN PERIPHERAL-BLOOD LYMPHOCYTES BY COLORIMETRIC PCR ASSAY AS A CLINICAL LABORATORY TOOL APPLIED TO DIFFERENT AT-RISK POPULATIONS 90
Post-translational modification by sumoylation and ubiquitinylation of H4 (D10S170), the product of first and most frequently observed RET-fused gene 88
PTC is a novel rearranged form of the ret proto-oncogene and is frequently detected in vivo in human thyroid papillary carcinomas. 87
Changes in cellular gene expression in rat thyroid epithelial cells transformed by the Kirsten murine sarcoma virus. 87
Seminal ribonuclease inhibits tumor growth and reduces the metastatic potential of Lewis lung carcinoma. 86
45th Annual Meeting of the Italian Cancer Society 85
The oncogene associated with human papillary thyroid carcinoma (PTC) is assigned to chromosome 10 q11-q12 in the same region as multiple endocrine neoplasia type 2A (MEN2A). 85
A potential pathogenetic mechanism for multiple endocrine neoplasia type 2 syndromes involves ret-induced impairment of terminal differentiation of neuroepithelial cells. 85
The PTC oncogene is able to dedifferentiate a rat thyroid epithelial cell line in culture 83
Verapamil reverts resistance to drug-induced apoptosis in Ki-ras-transformed cells by altering the cell membrane and the mitochondrial transmembrane potentials. 82
Activated RET/PTC oncogene elicits immediate early and delayed response genes in PC12 cells. 81
[On the fixation of thyroid hormones by the isolated cells of Ehrlich's adenocarcinoma (ascites tumor).] 80
[ON THE DISTRIBUTION OF 3,5,3'-TRIIODO-L-THYRONINE (T3) AND L-THYROXINE (T4) IN THE TISSUE OF MICE BEARING ASCITES TUMOR (EHRLICH'S ADENOCARCINOMA).] 80
European Thyroid Association: 2006 in Naples. 79
Biosynthesis of thyroglobulin: Partial characterization of a labeled 6 S precursor 79
A potential pathogenetic mechanism for multiple endocrine neoplasia type 2 syndromes involves ret-induced impairment of terminal differentiation of neuroepithelial cells 78
Preferential expression of the dbl protooncogene in some tumors of neuroectodermal origin. 78
In vivo and in vitro growth-inhibitory effect of bovine seminal ribonuclease on a system of rat thyroid epithelial transformed cells and tumors. 78
RET\PTC activation in human thyroid carcinomas 77
Development of mammary and cutaneous gland tumors in transgenic mice carrying the RET/PTC1 oncogene. 77
Molecular characterization of RET/PTC3; a novel rearranged version of the RETproto-oncogene in a human thyroid papillary carcinoma. 76
Refined localization to contiguous regions on chromosome 10q of the two genes (H4 and RET) that form the oncogenic sequence PTC. 76
The Kirsten murine sarcoma virus induces rat thyroid carcinomas in vivo 76
On the dissociation of human thyroglobulin by ultraviolet irradiation 76
Block in the expression of differentiation markers of rat thyroid epithelial cells by transformation with Kirsten murine sarcoma virus. 76
Activation of RET oncogene and thyroid carcinogenesis 76
Effetti dell'interferone sulll'espressione del genoma dell'FLV nelle cellule eritroleucemiche di Friend 76
Identification of a chimeric gene frequently activated in human thyroid papillary carcinomas 74
Patologia Generale 73
Different mutations of the RET gene cause different human tumoral diseases. 73
Cytostatic Activity of Adenosine Triphosphate-Competitive Kinase Inhibitors in BRAF Mutant Thyroid Carcinoma Cells 72
Development of thyroid papillary carcinomas secondary to tissue specific expression of the RET/PTC1 oncogene in transgenic mice 71
Activation of RET as a dominant transforming gene by germline mutatios of MEN2A and MEN2B 71
Presence of physiologically stimulated RET in adult rat brain: induction of RET expression during nerve regeneration. 71
Molecular mechanisms of RET activation in human cancer. 71
Nino Salvatore's contribution to scientific collaboration between Europe and the US in endocrinology. 70
CHARACTERIZATION OF AN INVERSION ON THE LONG ARM OF CHROMOSOME-10 JUXTAPOSING D10S170 AND RET AND CREATING THE ONCOGENIC SEQUENCE RET PTC 70
RET 69
PRODUCTION OF TRANSGENIC MICE EXPRESSING THE KI-RAS ONCOGENE UNDER THE CONTROL OF A THYROGLOBULIN PROMOTER 68
A mos oncogene-containing retrovirus, myeloproliferative sarcoma virus, transforms rat thyroid epithelial cells and irreversibly blocks their differentiation pattern. 68
Virus-specific rna and viral proteins in polyribosomesof cells transformed by the murine sarcoma-leukemia virus:Analysis by molecular hibridation immunoprecipitation and polyacrylamide gel electrophoresis 68
The cooperation between viral ras genes and different immortalizing genes induces the transformation of rat thyroid epithelial cells 67
Molecular mechanisms of RET activation in human neoplasia. 66
Increased in vivo phosphorylation of ret tyrosine 1062 is a potential pathogenetic mechanism of multiple endocrine neoplasia type 2B. 66
The RFG oligomerization domain mediates kinase activation and re-localization of the RET/PTC3 oncoprotein to the plasma membrane. 65
Molecular mechanisms of RET activation in human neoplasia 65
Molecular cloning of PTC,a new oncogene found activated in human thyiroid papillary carcinomas and their lymph node metastates 65
Expression of the RET receptor tyrosine kinase and GDNFR-alpha in normal and leukemic human hematopoietic cells and stromal cells of the bone marrow microenvironment. 64
27S THYROID IODOPROTEIN. ISOLATION AND PROPERTIES. 64
Molecular mechanisms of Ret activation in human neoplasia 63
Oncogenes of DNA and RNA tumor viruses and the origin of cellular oncogenes. 63
Changes in nuclear proteins on transformation of rat epithelial thyroid cells by a murine sarcoma retrovirus. 63
Dissociation between transformed and differentiated phenotype in rat thyroid epithelial cells after transformation with a temperature-sensitive mutant of the Kirsten murine sarcoma virus. 63
Biosynthesis of thyroid iodoproteins in vivo and in tissue slices. 63
Identification and characterization of two labeled intermediates in the biosynthesis of rat thyroglobulin. 63
Differential diagnosis of thyroid nodules using fine-needle aspiration cytology and oncogene mutation screening: are we ready? 63
Dbl expression driven by the neuron specific enolase promoter induces tumor formation in transgenic mice with a p53(+/-) genetic background. 62
Totale 23.166
Categoria #
all - tutte 67.272
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 67.272


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021928 0 0 0 0 0 211 117 84 136 79 214 87
2021/20222.549 109 50 126 112 105 186 193 194 262 182 357 673
2022/20233.984 322 145 155 292 351 380 391 406 400 319 382 441
2023/20244.984 274 323 478 337 371 374 726 527 223 293 581 477
2024/20258.590 720 660 405 383 416 513 1.011 653 797 686 1.693 653
2025/20265.568 1.154 605 947 940 1.664 258 0 0 0 0 0 0
Totale 29.201